Literature DB >> 25241914

CD28⁻ CD8⁺ T cells are significantly reduced and correlate with disease duration in juveniles with type 1 diabetes.

Danielle N Yarde1, Kristina Lorenzo-Arteaga1, Kevin P Corley2, Monina Cabrera2, Nora E Sarvetnick3.   

Abstract

Type 1 diabetes (T1D) is a chronic disease caused by autoimmune destruction of insulin-producing pancreatic β-cells. T1D is typically diagnosed in children, but information regarding immune cell subsets in juveniles with T1D is scarce. Therefore, we studied various lymphocytic populations found in the peripheral blood of juveniles with T1D compared to age-matched controls (ages 2-17). One population of interest is the CD28(-) CD8(+) T cell subset, which are late-differentiated cells also described as suppressors. These cells are altered in a number of disease states and have been shown to be reduced in adults with T1D. We found that the proportion of CD28(-) cells within the CD8(+) T cell population is significantly reduced in juvenile type 1 diabetics. Furthermore, this reduction is not correlated with age in T1D juveniles, although a significant negative correlation between proportion CD28(-) CD8(+) T cells and age was observed in the healthy controls. Finally, correlation analysis revealed a significant and negative correlation between the proportion of CD28(-) CD8(+) T cells and T1D disease duration. These findings show that the CD28(-) CD8(+) T cell population is perturbed following onset of disease and may prove to be a valuable marker for monitoring the progression of T1D.
Copyright © 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD28(−) CD8(+) T cells; Juvenile type 1 diabetes; T suppressor cells

Mesh:

Substances:

Year:  2014        PMID: 25241914      PMCID: PMC4275001          DOI: 10.1016/j.humimm.2014.09.007

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  46 in total

1.  Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28(-)progeny, but IL-4 prevents loss of CD28 expression.

Authors:  M Labalette; E Leteurtre; C Thumerelle; C Grutzmacher; B Tourvieille; J P Dessaint
Journal:  Int Immunol       Date:  1999-08       Impact factor: 4.823

2.  Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

Authors:  Shelley Lindley; Colin M Dayan; Amanda Bishop; Bart O Roep; Mark Peakman; Timothy I M Tree
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

3.  'The honeymoon phase' in children with type 1 diabetes mellitus: frequency, duration, and influential factors.

Authors:  Majedah Abdul-Rasoul; Hessa Habib; Maha Al-Khouly
Journal:  Pediatr Diabetes       Date:  2006-04       Impact factor: 4.866

4.  Progressive decrease of CD8high+ CD28+ CD57- cells with ageing.

Authors:  J Merino; M A Martínez-González; M Rubio; S Inogés; A Sánchez-Ibarrola; M L Subirá
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

5.  Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999.

Authors: 
Journal:  Diabet Med       Date:  2006-08       Impact factor: 4.359

6.  Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis.

Authors:  Eduardo Davila; Young Mo Kang; Yong Wook Park; Hirokazu Sawai; Xiaowen He; Sergey Pryshchep; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

7.  Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis.

Authors:  M Hooper; E G Kallas; D Coffin; D Campbell; T G Evans; R J Looney
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

8.  Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.

Authors:  Todd M Brusko; Clive H Wasserfall; Michael J Clare-Salzler; Desmond A Schatz; Mark A Atkinson
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

9.  Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.

Authors:  Luigi Scotto; Afzal Jamal Naiyer; Sara Galluzzo; Paola Rossi; John Sanil Manavalan; Seunghee Kim-Schulze; Jianshe Fang; Riccardo Dalla Favera; Raffaello Cortesini; Nicole Suciu-Foca
Journal:  Hum Immunol       Date:  2004-11       Impact factor: 2.850

10.  Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells.

Authors:  Z Liu; S Tugulea; R Cortesini; N Suciu-Foca
Journal:  Int Immunol       Date:  1998-06       Impact factor: 4.823

View more
  5 in total

1.  Regulation of Diabetogenic Immunity by IL-15-Activated Regulatory CD8 T Cells in Type 1 Diabetes.

Authors:  Blair T Stocks; Christopher S Wilson; Andrew F Marshall; Emilee M Hoopes; Daniel J Moore
Journal:  J Immunol       Date:  2019-05-24       Impact factor: 5.422

2.  Connecting cognition, cardiology, and chromosomes: Cognitive reappraisal impacts the relationship between heart rate variability and telomere length in CD8+CD28- cells.

Authors:  Anoushka D Shahane; Angie S LeRoy; Bryan T Denny; Christopher P Fagundes
Journal:  Psychoneuroendocrinology       Date:  2019-11-14       Impact factor: 4.905

3.  Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.

Authors:  Shuping Zhang; Xing Ke; Suyun Zeng; Meng Wu; Jianfang Lou; Lei Wu; Peijun Huang; Lei Huang; Fang Wang; Shiyang Pan
Journal:  Cell Mol Immunol       Date:  2015-07-13       Impact factor: 11.530

4.  Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children.

Authors:  Aleksandra Starosz; Milena Jamiołkowska-Sztabkowska; Barbara Głowińska-Olszewska; Marcin Moniuszko; Artur Bossowski; Kamil Grubczak
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

5.  Th1/Th2 cytokines in Type 1 diabetes: Relation to duration of disease and gender.

Authors:  Hajar Vaseghi; Zohreh Jadali
Journal:  Indian J Endocrinol Metab       Date:  2016 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.